![Jose Zayas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jose Zayas
Keine laufenden Positionen mehr
Profil
Jose Zayas is the founder of Zaycor Industries Corp.
Prior to that, he worked as the Senior Vice President of Operations at BioPharmX Corp.
and as the VP of Quality Assurance & Regulatory Affairs at Ionetix Corp.
He holds a doctorate degree from The Ohio State University.
Ehemalige bekannte Positionen von Jose Zayas
Unternehmen | Position | Ende |
---|---|---|
Ionetix Corp.
![]() Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | General Counsel | 01.12.2018 |
Zaycor Industries Corp. | Gründer | - |
TREX WIND-DOWN, INC. | Geschäftsführer | 16.07.2019 |
Ausbildung von Jose Zayas
The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Ionetix Corp.
![]() Ionetix Corp. Medical SpecialtiesHealth Technology Ionetix Corp. engages in the development, manufacturing, and distribution of a novel class of superconductng cyclotrons for the point-of-care production of PET radioisotopes. It offers ION-12SC, a positron emission tomography (PET) radiopharmaceutical production system for producing N-13 ammonia (13NH3), which is used in PET myocardial perfusion imaging. The company is headquartered in Marblehead, MA. | Health Technology |
BioPharmX Corp.
![]() BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
Zaycor Industries Corp. |